Market Place
Sourcing Support
Gritstone Bio Shows Strengthening Phase 2 PFS Data for GRANITE
11 Nov 2024 //
GLOBENEWSWIRE
Gritstone files for bankruptcy in hope of keeping R&D afloat
11 Oct 2024 //
BIOSPACE
Gritstone Bio Takes Action To Preserve Value And Capital
10 Oct 2024 //
BUSINESSWIRE
Gritstone Bio Announces Ph 2 Data For GRANITE Immunotherapy
30 Sep 2024 //
GLOBENEWSWIRE
Gritstone Bio Reports Q2 2024 Results And Corporate Updates
13 Aug 2024 //
GLOBENEWSWIRE
Gritstone Bio To Host KOL Event On GRANITE For MSS-CRC
24 Jul 2024 //
GLOBENEWSWIRE
Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 Jul 2024 //
GLOBENEWSWIRE
Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13 Jun 2024 //
GLOBENEWSWIRE
Gritstone bio to Participate in Upcoming Investor and Scientific Conferences
04 Jun 2024 //
GLOBENEWSWIRE
Gritstone Bio Q1 2024 Financials And Corporate Update
09 May 2024 //
GLOBENEWSWIRE
Gritstone Q1 2024 Results, Corporate Updates On May 9
02 May 2024 //
GLOBENEWSWIRE
Gritstone Highlights samRNA COVID-19 Vaccine at ESCMID 2024
30 Apr 2024 //
GLOBENEWSWIRE
Gritstone bio Announces Appointment of Stephen Webster to its Board of Directors
29 Apr 2024 //
GLOBENEWSWIRE
Nature Medicine: Gritstone Neoantigen Vaccine Interim Data
15 Apr 2024 //
GLOBENEWSWIRE
Gritstone bio Presents Improvements to EDGE Platform at AACR 2024
08 Apr 2024 //
GLOBENEWSWIRE
Gritstone bio to Participate in Upcoming Investor and Scientific Conferences
08 Apr 2024 //
GLOBENEWSWIRE
Gritstone shares fall on shaky study results for colorectal cancer vaccine
02 Apr 2024 //
BIOPHARMADIVE
Gritstone Announces +ve Progression of Ph 2 Study of its Personalized Vaccine
01 Apr 2024 //
GLOBENEWSWIRE
Gritstone bio Announces Proposed Public Offering
01 Apr 2024 //
GLOBENEWSWIRE
Gritstone bio Announces Pricing of $32.5 Million Underwritten Public Offering
01 Apr 2024 //
GLOBENEWSWIRE
Gritstone ground down by phase 2 cancer vaccine fail
01 Apr 2024 //
FIERCE BIOTECH
Gritstone bio Reports Fourth Quarter and Full Year 2023 Financial Results
05 Mar 2024 //
GLOBENEWSWIRE
Gritstone lays off 40% of team after delaying COVID vax trial
01 Mar 2024 //
FIERCE BIOTECH
Gritstone bio Announces Workforce Reduction
29 Feb 2024 //
GLOBENEWSWIRE
Gritstone bio to Participate in Upcoming Investor and Scientific Conferences
21 Feb 2024 //
GLOBENEWSWIRE
Gritstone bio Announces Update to Comparative Phase 2b COVID-19 Clinical Trial
12 Feb 2024 //
GLOBENEWSWIRE
Gritstone`s BARDA-funded COVID vaccine hit with delay
12 Feb 2024 //
FIERCE PHARMA
Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08 Feb 2024 //
GLOBENEWSWIRE
Gritstone bio to Participate in Upcoming Investor Conference
17 Jan 2024 //
GLOBENEWSWIRE
Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 Jan 2024 //
GLOBENEWSWIRE
Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07 Dec 2023 //
GLOBENEWSWIRE
Gritstone bio to Participate in Upcoming Investor Conferences
20 Nov 2023 //
GLOBENEWSWIRE
Gritstone bio Reports Third Quarter 2023 Financial Results
08 Nov 2023 //
GLOBENEWSWIRE
Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07 Nov 2023 //
GLOBENEWSWIRE
Presentations at IDWeek Highlight Gritstone bio™s COVID-19 Vaccine
11 Oct 2023 //
GLOBENEWSWIRE
Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 Oct 2023 //
GLOBENEWSWIRE
Gritstone Announces Presentations from Ph 1 Studies Evaluating Vaccine Candidate
04 Oct 2023 //
GLOBENEWSWIRE
Gritstone gets $433M in BARDA funds to trial mRNA COVID-19 shot
28 Sep 2023 //
FIERCE BIOTECH
Gritstone Awarded BARDA Contract to Conduct Phase 2b of Candidate for COVID-19
27 Sep 2023 //
GLOBENEWSWIRE
Gritstone inks up to $433M contract with BARDA for Covid-19 vaccine trial
27 Sep 2023 //
ENDPTS
Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13 Sep 2023 //
GLOBENEWSWIRE
Gritstone bio to Participate in Upcoming Investor Conferences
05 Sep 2023 //
GLOBENEWSWIRE
Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
16 Aug 2023 //
GLOBENEWSWIRE
Gritstone bio and Genevant Sciences Announce Option and License Agreement
15 Aug 2023 //
GLOBENEWSWIRE
Gritstone bio Reports Second Quarter 2023 Financial Results
09 Aug 2023 //
GLOBENEWSWIRE
Gritstone bio Partners with Friends of Cancer Research (Friends) on the ctDNA
07 Aug 2023 //
GLOBENEWSWIRE
Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
17 Jul 2023 //
GLOBENEWSWIRE
Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13 Jun 2023 //
GLOBENEWSWIRE
Gritstone bio supports mRNA Covid-19 vaccine plans with Phase I publication
08 Jun 2023 //
CLINICAL TRIALS ARENA
Gritstone Announces Publication of Interim Results from Phase 1 Study of samRNA
08 Jun 2023 //
GLOBENEWSWIRE
Gritstone bio to Participate in Upcoming Investor Conferences
01 Jun 2023 //
GLOBENEWSWIRE
Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
24 May 2023 //
GLOBENEWSWIRE
Gritstone bio to Report 1Q 2023 FYR and Provide Corporate Update
03 May 2023 //
GLOBENEWSWIRE
Gritstone bio Presents Advances in Neoantigen & Cancer Vaccine at the 2023 AACR
17 Apr 2023 //
GLOBENEWSWIRE
Gritstone bio Presents 6-month Neutralizing Antibody (nAb) Data at ECCMID 202
17 Apr 2023 //
GLOBENEWSWIRE
Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 Apr 2023 //
GLOBENEWSWIRE
Gritstone bio Announces Presentations Evaluating samRNA Against SARS-CoV-2
04 Apr 2023 //
GLOBENEWSWIRE
Gritstone bio Announces Presentations on Cancer Vaccine Programs at AACR
15 Mar 2023 //
GLOBENEWSWIRE
Gritstone bio Reports Fourth Quarter and Full Year 2022 Financial Results
09 Mar 2023 //
GLOBENEWSWIRE
Gritstone bio to Report Fourth Quarter and Full Year 2022 Financial Results
02 Mar 2023 //
GLOBENEWSWIRE
